INJ
Injective
Market cap$805M
Updated - ago
Injective (INJ) traded flat with a +0.07% move over the last 24 hours to $8.2806, consolidating after a recent rally triggered by Nasdaq approving Canary Capital's Canary Staked INJ ETF (INJC).1 While the Form 8-A registration marked a milestone as the first U.S. exchange-traded product focused on Injective, price action has paused as market participants await final S-1 effectiveness to gauge actual institutional inflows.1 Derivatives activity reflected this balanced sentiment, marked by a neutral 0.0004% funding rate and $5.8M in open interest.
Injective is a Layer 1 blockchain platform specifically engineered to serve decentralized finance applications and enable interoperability across multiple blockchain ecosystems. Built from the ground up with specialized financial infrastructure modules, Injective provides developers with native tools and capabilities for constructing a wide range of DeFi applications including decentralized exchanges, prediction markets, lending protocols, and other financial instruments. The network distinguishes itself through its decentralized cross-chain bridging architecture, which enables seamless communication and asset transfers between Injective and numerous external blockchains spanning both EVM-compatible networks such as Ethereum and non-EVM chains like Solana. This interoperability focus addresses a critical need in the fragmented blockchain landscape, allowing users and developers to leverage assets and liquidity from multiple chains within a unified environment. As a Layer 1 solution rather than a sidechain or rollup, Injective operates as an independent blockchain with its own validator set and consensus mechanism, providing sovereignty and security guarantees. The INJ token serves as the native asset of the Injective ecosystem, playing a role in network governance and economic incentives.